SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors closely monitor a high-stakes legal dispute with Nippon Shinyaku regarding the distribution rights for its Duchenne muscular dystrophy therapy, Deramiocel. The community is actively discussing the impact of this litigation on the upcoming August PDUFA date, with many bullish investors framing the lawsuit as a strategic catalyst that could return full commercial rights to Capricor ahead of the drug's anticipated approval.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as retail investors react to a combination of workforce restructuring, record-breaking trading volumes, and bullish anticipation for new revenue streams like AI-driven trading tools and prediction markets. Community members are actively debating the stock's potential for a breakout, with many focusing on the impact of increased platform engagement during major sporting and market events.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant institutional interest as the community anticipates imminent Phase 3 52-week data, which is widely viewed as a major catalyst for potential M&A activity. Traders are actively discussing the stock's tight float and the strategic significance of recent supply agreements alongside upcoming conference presentations.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is experiencing heightened trading volume and volatility as investors speculate on potential data center tenant agreements amid ongoing boardroom leadership conflicts. Community sentiment remains polarized, with some traders optimistic about the company's energy infrastructure assets while others are wary of the persistent management drama and the lack of confirmed commercial contracts.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is experiencing significant investor friction as stakeholders express frustration over stagnant stock performance and perceived management inertia, despite ongoing clinical progress and established revenue streams. Community discussion is heavily centered on the company's valuation gap compared to sector peers, with many calling for a potential buyout or leadership change to catalyze a long-awaited recovery.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure is surging after the FDA reversed its previous stance and now allows the company to use three-year Phase I/II data for an accelerated approval BLA filing, effectively pulling forward the commercialization timeline for its Huntington's disease gene therapy. The community is actively discussing the significant regulatory win and the potential for a rapid re-rating, with traders highlighting the strategic importance of the ClearPoint navigation system to the procedural rollout.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

LABD is experiencing heightened trading activity as the community remains divided over whether to capitalize on the biotech sector's volatility through short-term scalp trades or hold despite significant losses from the ETF's prolonged decline. Discussions are centered on the upcoming influence of key economic figures like Kevin Warsh, the impact of XBI's technical channel breakouts, and the recurring behavioral patterns traders are attempting to exploit during this period of market uncertainty.

Arqit Quantum, Inc. engages in the provision of cybersecurity services via satellite and terrestrial forms. Its product is QuantumCloud which secures devices with cloud-based quantum encryption. The company was founded by David John Williams and David James Bestwick on April 26, 2021 and is headquartered in London, the United Kingdom.

Arqit Quantum Inc

Arqit Quantum is experiencing significant momentum as investors pivot toward quantum-safe cybersecurity, with the stock drawing attention for its low float and heavy institutional ownership. The community is actively discussing its potential for a parabolic squeeze, citing recent partnerships and the critical industry demand for post-quantum cryptographic solutions.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF is trending as investors rotate back into the sector, bolstered by a wave of M&A activity and positive data readouts for key oncology therapies. The community is actively discussing the potential for a sustained breakout, while closely monitoring clinical trial milestones and regulatory updates that act as primary catalysts for the ETF's performance.

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Carmax Inc

CarMax is facing significant investor scrutiny after reporting a major earnings miss and signaling weak sales, leading some to question the company's turnaround strategy amidst a challenging used-vehicle market. While activists push for leadership and operational changes to improve efficiency, the community remains deeply divided between those viewing the current valuation as a deep-value opportunity and others anticipating further downside due to lingering economic headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VPGI Corp. is a development stage company. As of June 30, 2006, the Company had no operations. The company previously offered digital media solutions, as well as contact centre customer service solutions through CIMphonyT, a suite of computer telephony integration software products and services. The company was founded on July 13, 1984 and is headquartered in Houston, TX.

VPGI Corp

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$4.40
Prev Close	$4.50
Open	$4.40
Dividend Yield	N/A
50-Day Moving Average	$0.0189
Beta	0.00
Avg. Volume	0.00
PE Ratio	N/A

52-Week High	$0.05
52-Week Low	$0.0102
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

VPGIVelocity Portfolio Group, Inc

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest VPGI News